Advances in the study of drugs to combat cognitive impairment in schizophrenia

A study by the UPV/EHU has assessed whether drugs used to delay cognitive deterioration

GPs prescribe more opioids for pain in poor Northern areas, study reveals

English patients living in poorer areas are likely to be prescribed more opioids by

The opioid crisis: What we should learn from the AIDS epidemic

There are important lessons to be learned from the successes and failures of the

FDA Approves ProAir Digihaler

JERUSALEM–(BUSINESS WIRE)–Dec 21, 2018–Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that

FDA Approves Motegrity

Cambridge, Mass. – December 17, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG) has

Ovid Therapeutics Announces Plans to Move into a Phase 3 Trial in Pediatric Patients Based on End-of-Phase 2 Meeting for OV101 in Angelman Syndrome

NEW YORK, Dec. 06, 2018 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical

Government investigation finds flaws in FDA’s orphan drug program

The Food and Drug Administration has failed to ensure that drugs given prized rare-disease

Alkermes Announces Positive Topline Results From ENLIGHTEN-2 Phase 3 Study of ALKS 3831 in Patients With Schizophrenia

DUBLIN, Nov. 29, 2018 /PRNewswire/ — Alkermes plc (Nasdaq: ALKS) today announced positive topline

FDA Approves Gamifant

November 20, 2018 — The U.S. Food and Drug Administration today approved Gamifant (emapalumab)

Epinephrine personal autoinjectors cost-effective at $24

(HealthDay)—In a simulation of children with peanut allergy, epinephrine personal autoinjectors are cost-effective at

Clementia Announces Plan to Submit a New Drug Application for Palovarotene for the Treatment of FOP Based on Positive Phase 2 Results

MONTREAL, Oct. 23, 2018 (GLOBE NEWSWIRE) — Clementia Pharmaceuticals Inc. (Nasdaq: CMTA), a clinical-stage

US health chief says overdose deaths beginning to level off

The number of U.S. drug overdose deaths has begun to level off after years

FDA Approves Dupixent (dupilumab) for Moderate-to-Severe Asthma

PARIS and TARRYTOWN, N.Y., Oct. 19, 2018 /PRNewswire/ — Sanofi (EURONEXT: SAN) (NYSE: SNY)

Common use of antipsychotics shown ineffective for delirium in intensive care patients

Critically ill patients in intensive care units (ICUs) did not benefit from two antipsychotic

Prescription opioid and benzodiazepine misuse linked with suicidal thoughts

Misuse of prescription opioids or benzodiazepines (such as Xanax) was associated with suicidal ideation

Research assesses geographic distribution of new antibiotics following market introduction

There is a growing need for new antibiotics to help combat the looming threat

Despite crisis patients perceive opioids as superior and expect them for postsurgical pain

Even with concerns about addiction, side effects and the other risks of opioids dominating

Truvada for PrEP Prevents HIV, So Why Have Prescription Fills Dropped 30% Since 2015?

    Introduced in 2012, Truvada for PrEP (pre-exposure prophylaxis) is a mixture of

Oryzon Announces First Patient Enrolled in REIMAGINE: a Phase IIa Clinical Trial with Vafidemstat (ORY-2001) in Aggressiveness

MADRID, Spain and CAMBRIDGE, Mass., Oct. 09, 2018 (GLOBE NEWSWIRE) — Oryzon Genomics S.A.

Lilly’s Investigational Dual GIP and GLP-1 Receptor Agonist Shows Significant Reduction in HbA1c and Body Weight in People With Type 2 Diabetes

INDIANAPOLIS, Oct. 4, 2018 /PRNewswire/ — Results from a phase 2b clinical trial of

Genentech Announces New Data for Risdiplam in Spinal Muscular Atrophy (SMA) at the World Muscle Society Congress

South San Francisco, CA — October 3, 2018 — Genentech, a member of the

Opioid-related hospital use up in elderly adults

(HealthDay)—Rates of opioid-related prescriptions and health care utilization are rising among seniors, according to

6 Doctor-Approved Tips For Cold And Flu Season

1. Zinc works 2. There’s nothing wrong with treating (some) symptoms 3. If you’re going use

Eisai Announces FDA Approval of Fycompa in Pediatric Patients as Young as 4 Years Old for the Treatment of Partial-Onset Seizures

WOODCLIFF LAKE, N.J., Sept. 28, 2018 /PRNewswire/ — Eisai Inc. announced today that the

Brexit will affect the UK’s ability to tackle illicit drugs trade, warn experts

Exclusion from the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) because of

Genentech’s Investigational Medicine Entrectinib Showed a Durable Response of More Than Two Years in People With a Specific Type of Lung Cancer

South San Francisco, CA — September 24, 2018 — Genentech, a member of the

AbbVie Presents Upadacitinib Longer-Term (32-Week) and Patient-Reported Outcomes Data from Phase 2b Atopic Dermatitis Study at 27th European Academy of Dermatology and Venereology (EADV) Congress

NORTH CHICAGO, Ill., Sept. 13, 2018 /PRNewswire/ — AbbVie (NYSE: ABBV), a research-based global

One in four older adults prescribed a benzodiazepine goes on to risky long-term use

They may start as well-intentioned efforts to calm anxiety, improve sleep or ease depression.

FDA Approves Imbruvica (ibrutinib) Plus Rituximab for Patients with Waldenström’s Macroglobulinemia

HORSHAM, Pa., August 27, 2018 – The Janssen Pharmaceutical Companies of Johnson & Johnson

FDA warns of common diabetes meds’ link to dangerous genital infection

(HealthDay)—Rare but serious genital infections, as well as one death, have been reported in